Patent ID: 7914992

Claim:
A method for the prophylaxis or treatment of porcine respiratory disease complex (PRDC) or one or more clinical signs of PRDC in a group of porcine, wherein said PRDC is caused by PCV2 and at least one further pathogen selected from the group consisting of Mycoplasma hyopneumoniae, Mycoplasma hyorhinis , and combinations thereof, wherein the method comprises administering to a porcine in need a therapeutically effective amount of recombinant PCV2 ORF2 protein or an immunogenic composition comprising recombinant PCV2 ORF2 protein, wherein the therapeutically effective amount of recombinant PCV2 ORF2 protein comprises about 4 μg to 400 μg of recombinant PCV2 ORF2 protein, and wherein the immunogenic composition comprising recombinant PCV2 ORF2 protein further comprises a polymer of acrylic or methacrylic acid.